Mobile teledermoscopy for patients at high risk of cutaneous melanoma: A single-arm, feasibility study of a clinical intervention at two tertiary centres (MOBILEMEL)

被引：0
|
作者：
Martin, Arthur [1 ]
Cust, Anne [2 ]
Lo, Serigne [3 ]
Morton, Rachael [4 ]
Kasparian, Nadine [5 ]
Teh, Natalie [6 ]
Collgros, Helena [7 ,8 ]
Martin, Linda [9 ]
Guitera, Pascale [10 ]
机构：
[1] Melanoma Inst Australia, Wollstonecraft, NSW, Australia
[2] Univ Sydney, Melanoma Inst Australia, Joint Venture Canc Council, Daffodil Ctr, Sydney, NSW, Australia
[3] Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia
[4] Univ Sydney, Camperdown, NSW, Australia
[5] Univ New South Wales, Sydney, NSW, Australia
[6] Univ New South Wales, Fac Med, Sydney, NSW, Australia
[7] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia
[8] Royal Prince Alfred Hosp, Sydney Melanoma Diagnost Ctr, Sydney, NSW, Australia
[9] Melanoma Inst Australia, Sydney, NSW, Australia
[10] Melanoma Inst Australia, Sydney, NSW, Australia
来源：
AUSTRALASIAN JOURNAL OF DERMATOLOGY | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：82 / 82
页数：1
相关论文
共 50 条
  • [31] Development, implementation, and feasibility of site-specific hepatitis C virus treatment workflows for treating vulnerable, high-risk populations: protocol of the Erase Hep C study - a prospective single-arm intervention trial
    Desai, Anmol
    O'Neal, Lauren
    Reinis, Kia
    Chang, Patrick
    Brown, Cristal
    Stefanowicz, Michael
    Kuang, Audrey
    Agrawal, Deepak
    Bhavnani, Darlene
    Mercer, Tim
    PILOT AND FEASIBILITY STUDIES, 2023, 9 (01)
  • [32] Development, implementation, and feasibility of site-specific hepatitis C virus treatment workflows for treating vulnerable, high-risk populations: protocol of the Erase Hep C study — a prospective single-arm intervention trial
    Anmol Desai
    Lauren O’Neal
    Kia Reinis
    Patrick Chang
    Cristal Brown
    Michael Stefanowicz
    Audrey Kuang
    Deepak Agrawal
    Darlene Bhavnani
    Tim Mercer
    Pilot and Feasibility Studies, 9
  • [33] Idarubicin, cytarabine, and nivolumab in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a single-arm, phase 2 study
    Ravandi, Farhad
    Assi, Rita
    Daver, Naval
    Benton, Christopher B.
    Kadia, Tapan
    Thompson, Philip A.
    Borthakur, Gautam
    Alvarado, Yesid
    Jabbour, Elias J.
    Konopleva, Marina
    Takahashi, Koichi
    Kornblau, Steven
    DiNardo, Courtney D.
    Estrov, Zeev
    Flores, Wilmer
    Basu, Sreyashi
    Allison, James
    Sharma, Padmanee
    Pierce, Sherry
    Pike, Allison
    Cortes, Jorge E.
    Garcia-Manero, Guillermo
    Kantarjian, Hagop M.
    LANCET HAEMATOLOGY, 2019, 6 (09): : E480 - E488
  • [34] Complex lifestyle intervention among inactive older adults with elevated cardiovascular disease risk and obesity: a mixed-method, single-arm feasibility study for RESTART-a randomized controlled trial
    Deraas, Trygve S.
    Hopstock, Laila
    Henriksen, Andre
    Morseth, Bente
    Sand, Anne Sofie
    Njolstad, Inger
    Pedersen, Sigurd
    Sagelv, Edvard
    Johansson, Jonas
    Grimsgaard, Sameline
    PILOT AND FEASIBILITY STUDIES, 2021, 7 (01)
  • [35] Neoadjuvant tislelizumab combined with CAPOX for MSS/pMMR high-risk locally advanced colon cancer: A single-arm, exploratory phase II clinical study
    Lin, M.
    Xia, Z.
    Chen, H.
    Liao, C.
    Huang, W.
    Li, H.
    Huang, J.
    Liu, M.
    Song, R.
    Xie, Y.
    Zhang, X.
    Liang, J.
    Gan, J.
    Guo, Y.
    Zhang, S.
    ANNALS OF ONCOLOGY, 2024, 35 : S21 - S21
  • [36] A prospective, single-arm, phase II clinical study of tislelizumab in combination with lenvatinib for perioperative treatment of resectable primary hepatocellular carcinoma with high risk of recurrence.
    Song, Tianqiang
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [37] PURE-02: An open-label, single-arm, feasibility study of neoadjuvant pembrolizumab before Radical Nephroureterectomy (RNU) in patients with high-risk, Upper-Tract Urothelial Carcinoma (UTUC)
    Necchi, A.
    Martini, A.
    Raggi, D.
    Cucchiara, V.
    Colecchia, M.
    Luciano', R.
    Ross, J.
    Mazzone, E.
    Scuderi, S.
    Barletta, F.
    Capitanio, U.
    Salonia, A.
    Briganti, A.
    Messina, A.
    Montorsi, F.
    EUROPEAN UROLOGY, 2021, 79 : S1089 - S1089
  • [38] Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR) a prospective, multicentre, single-arm study
    Vahl, Torsten P.
    Thourani, Vinod H.
    Makkar, Raj R.
    Hamid, Nadira
    Khalique, Omar K.
    Daniels, David
    McCabe, James M.
    Satler, Lowell
    Russo, Mark
    Cheng, Wen
    George, Isaac
    Aldea, Gabriel
    Sheridan, Brett
    Kereiakes, Dean
    Golwala, Harsh
    Zahr, Firas
    Chetcuti, Stanley
    Yadav, Pradeep
    Kodali, Susheel K.
    Treede, Hendrik
    Baldus, Stephan
    Amoroso, Nicholas
    Ranard, Lauren S.
    Pinto, Duane S.
    Leon, Martin B.
    LANCET, 2024, 403 (10435): : 1451 - 1459
  • [39] NEO-GAP: A phase II single-arm prospective feasibility study of neoadjuvant gemcitabine/cisplatin/nab-paclitaxel for resectable high-risk intrahepatic cholangiocarcinoma.
    Maithel, Shishir K.
    Javle, Milind M.
    Mahipal, Amit
    Lin, Bruce Shih-Li
    Akce, Mehmet
    Switchenko, Jeffrey M.
    Rupji, Manali
    Cao, Hop Tran
    Cleary, Sean P.
    Rocha, Flavio G.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [40] Rationale and Study Design for a Single-Arm Phase IIa Study Investigating Feasibility of Preventing Ischemic Cerebrovascular Events in High-Risk Patients with Acute Non-disabling Ischemic Cerebrovascular Events Using Remote Ischemic Conditioning
    Liu, Shi-Meng
    Zhao, Wen-Le
    Song, Hai-Qing
    Meng, Ran
    Li, Si-Jie
    Ren, Chang-Hong
    Ovbiagele, Bruce
    Ji, Xun-Ming
    Feng, Wu-Wei
    CHINESE MEDICAL JOURNAL, 2018, 131 (03) : 347 - 351
12345